The team at Algorithmic Intuition has worked together for over a decade with a common goal: advancing the ability to detect human context and activity. Through the years, we have acquired deep expertise in sensor algorithms, machine learning, consumer products., and the business models needed to make these products successful.
Our most recent company, Sensor Platforms Inc (SPI), was acquired by Audience Inc in 2014. At SPI, our team worked to develop advanced sensor fusion and powerful, embedded, machine-learning algorithms for the mobile industry.
Now, we have a new mission, we are striving to extend the state-of-the-art in eldercare. Our vision is to make elder-care monitoring as respectful, unobtrusive, useful, and secure as possible.
Dan Brown | CEO / Founder
Dan is a highly accomplished, goal-driven, seasoned executive in the areas of sales and marketing, corporate development, market strategy, business development, client acquisition and strategic business planning. He has demonstrated more than 25 years of broad-based experience in building business from the ground-up and developing and implementing corporate strategies via business development and team building. Dan was CEO of Sensor Platforms Inc from 2010 until its acquisition by Audience Inc in 2014. Before that he was Technology Partner at Arrowpath Venture Partners for 10 years and where he lead the investment in Sensor Platforms. Previously he has been VP of Engineering, of Marketing and of Business Development across companies such as Ceon, CenterPoint Broadband, Mayan Networks, First World Communications and British Telecom.
Dr. Kevin Shaw | CTO / Founder
Kevin is a lifelong entrepreneur with deep experience in startups, semiconductors, business development, product development and team building. He has a PhD in EE/MEMS from Cornell University, a Masters in Management from Stanford University’s Graduate School of Business and 30 U.S. Patents in MEMS and algorithms. He is Adjunct Faculty at Singularity University for MEMS, Sensors and IOT. Kevin was CTO of Sensor Platforms Inc from 2009 until its acquisition by Audience in 2014. Before that he established the Sensor Algorithms team and ran Business Development. Previously, he co-founded his first company soon after college (sold in 2004) and worked at Kionix Inc, a MEMS semiconductor foundry as its 3rd employee (acquired in 2000).
David Chersky | VP Operations
David Chersky is a medical device operations and manufacturing professional with more than 20 years experience in the field. He holds APICS CPIM and CIRM certifications and has 5 issued patents. Prior to joining Algorithmic Intuition, David served as Vice President of Operations at Endoclear LLC where he lead the design, development and manufacturing of the Liberator closed suction system and Restore2 endotracheal tube clearing products as well as the successful sales of these assets to Avanos Medical in 2019. Prior to Endoclear, David served as Director of Operations for Endoscopic Technologies where he oversaw a 15x growth in revenue and 9% gross margin improvement while adding more than 100 products to the portfolio. David’s device manufacturing experience includes cardiac surgery tools, surgical robotics, endoscopy, RF ablation and respiratory health products. David lives in Northern California and spends off work hours shuttling his two children between travel baseball and horseback riding.
Eric Llewelyn | Chief Compliance Officer
An experienced and accomplished Quality & Regulatory Affairs professional with over 25 years of demonstrated experience in the medical and pharmaceutical industries. Eric brings a proven track record of excellence in developing personnel and highly proficient Quality Management Systems. Exceptionally knowledgeable in standards relating to Medical Devices sterilization, Laboratory Science, cGMP, Quality Management, and ISO Standards. A proven background working with the Food and Drug Administration, Centers for Disease Control, National Institutes of Occupational Health, Notified Bodies, and foreign regulatory agencies.
Alex Zhdankin | VP Eng
Alex is a network and software engineer with 25 years’ experience working in both large established firms and startups. He has deep experience leading teams for large distributed and mission critical systems; systems that have been deployed in commercial companies and government organizations domestically and across the globe, including the Federal Aviation Administration (FAA) and DoD.
Prior to Ai2, Alex worked at Cisco Systems where he designed and led the redesign of the device/network programmability stack, which is now being shipped on 2 million devices every year. Before that he was Chief Software Architect at Harris Corporation Network Management Business Unit, where he led industry-wide standardization efforts on information modeling and management APIs in the areas of Telecommunications and IT management.
Alex has a Masters of EE degree from Nizhny Novgorod State Technical University, Russia where he graduated Summa Cum Laude in 1994. He holds a number of US and International Patents.
Martyn Ansell | Chief Financial Officer
Martyn Ansell joined Algorithmic Intuition as Chief Financial Officer in November 2021. He has over 30 years of financial and operational experience and is responsible for overseeing the financial operations of the company and executing on the company’s financial strategy.
Prior to joining Algorithmic Intuition Mr. Ansell was the CFO at California Brazing, a Newark, CA based company providing brazing and machining services to the semiconductor and aerospace & defense industries.
Prior to joining California Brazing, Mr. Ansell spent 7 years as the CFO at Molecular Devices, a Danaher operating company based in San Jose, CA. Molecular Devices develops and manufactures equipment used in drug research & development by pharmaceutical companies, research institutes and universities.
In addition, Mr. Ansell spent over 6 years as the CFO of Vistec Semiconductor Systems, a global leader in the development and manufacture of metrology & inspection and electron-beam lithography equipment for the semiconductor industry. He also spent over 12 years at Applied Materials, a manufacturer of semiconductor capital equipment, where he held a number of senior financial management positions. Mr. Ansell has also held positions at Coopers & Lybrand, in San Jose, California and Ernst & Young in Bristol, England.
Mr. Ansell earned a Bachelor of Arts degree in Accounting and Finance with Honors, from the Manchester Metropolitan University, Manchester, England and is a member of the American Institute of Certified Public Accountants.
Mr. Ansell is from London, England and resides in Reno, Nevada.
Cindy Byers Atha | VP of Sales
Cindy Atha is a highly experienced sales and marketing executive with leadership history in commercial management roles at Atossa Genetics, Depomed, Inc. and Amylin Pharmaceuticals, innovative biotechnology companies, as well as AstraZeneca, one of the world's leading pharmaceutical companies. Most recently, Ms. Atha led the commercialization of Atossa’s medical devices and laboratory services for breast cancer and served as the Executive Director for a non-profit organization that pulled together healthcare stakeholders to collaborate in the development of treatments and a cure for an ultra-rare disease.
Prior to joining Atossa, Ms. Atha was Vice President of Managed Markets for Depomed, leading a team that focused on third party reimbursement, pricing, and distribution management. While Vice President of Managed Markets and Trade at Amylin Pharmaceuticals, her team was twice recognized for "Best Marketing Programs and People" for a small manufacturer and achieved the 2012 DIANA Award for best new product introduction. Ms. Atha began her 24 years of pharmaceutical experience in field sales with Merck & Co. and then moved to AstraZeneca where she advanced into senior sales leadership. She has received more than 16 sales awards for exceptional individual and group performance including AstraZeneca's prestigious "Leadership Excellence Award."
Ms. Atha helped bring over 20 new pharmaceutical products to market and gained formative experience as an account executive with Scientific Technologies, promoting the sale of research and medical equipment to leading biotechnology companies and medical centers. She serves on the Board of Directors for Operation of Hope, a non-profit organization that provides facial reconstructive surgeries to poor children around the world. She is active with the American Heart Association and is a mentor to start-up companies in sales and marketing. Ms. Atha received her Bachelor of Science in Zoology from North Carolina State University in Raleigh, North Carolina and her Master of Health Administration at the University of Southern California in Los Angeles.